ArticlesLong-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
Kim BK, Hong SJ, Lee YJ, et al.
Journal: Lancet
First published: July 30, 2022 DOI: 10.1016/S0140-6736(22)00916-3
Kim BK, Hong SJ, Lee YJ, et al.
Journal:Lancet
First published: July 30, 2022 DOI: 10.1016/S0140-6736(22)00916-3